| Date | Title | Description |
| 29.06.2026 | FDA Clears United Therapeutics LungFX: Lung Transplant Device for Discarded Donor Organs | By Mike Gonzales
Published: Jun 29 2026, 10:28 AM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 30.04.2026 | TransMedics Announces Strategic Investment In PAD Aviation To Build European Transplant Logistics Network | TransMedics Group, a medical technology company transforming organ transplant therapy, has entered into a definitive agreement to invest in PAD Aviation, a premier Germany-based private aviation operator, to lay the foundation for a dedicat... |
| 31.07.2024 | TransMedics Reports Second Quarter 2024 Financial Results | ANDOVER, Mass., July 31, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fa... |
| 18.07.2024 | TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ANDOVER, Mass., July 18, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fa... |
| 17.07.2024 | TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024 | ANDOVER, Mass., July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver fai... |
| 21.06.2024 | TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ANDOVER, Mass., June 21, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fa... |
| 30.04.2024 | TransMedics Reports First Quarter 2024 Financial Results | ANDOVER, Mass., April 30, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver f... |
| 04.04.2024 | Технология, позволяющая органам работать вне тела | Перфузия позволяет сохранить жизнь донорского органа вне тела, что даёт хирургам дополнительное время и увеличивает количество возможных трансплантаций.
Перфузионный аппарат, в котором находится печень умершего донора. Аппарат перекачивает ... |
| 18.08.2023 | TransMedics Completes Acquisition of Summit Aviation | TransMedics (Nasdaq: TMDX), an Andover, MA-based medical technology company, acquired Summit Aviation, a charter flight operator.
The amount of the deal was not disclosed.
The acquisition enables the establishment of TransMedics Aviation as... |
| 17.04.2023 | TransMedics to Report First Quarter 2023 Financial Results on May 1, 2023 | ANDOVER, Mass., April 17, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") TMDX, a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, tod... |
| 15.09.2022 | CIBC Innovation Banking Provides $60 Million Debt Financing to TransMedics Group Inc. | BOSTON–(BUSINESS WIRE)–September 15, 2022–
CIBC Innovation Banking is pleased to announce a new debt financing for Massachusetts-based TransMedics Group, Inc. (“TransMedics”), a market leading medical technology company that focuses on orga... |
| 24.06.2022 | Organ Preservation Market is anticipated to reach a market value of USD 377.97 million by 2030, with a CAGR of 6.93% | The value of the organ preservation market in 2020 was worth USD 193.49 million and is expected to grow at a CAGR of 6.93%, and it is expected to reach a market value of USD 377.97 million by 2030.
/EIN News/ -- New York, United States, Jun... |
| 10.11.2021 | TransMedics Reports Third Quarter 2021 Financial Results | ANDOVER, Mass., Nov. 9, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fai... |
| 04.11.2021 | TransMedics Announces Positive Top Line Results From the U.S. Randomized OCS DCD Heart Trial | ANDOVER, Mass., Nov. 4, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fai... |
| 29.09.2021 | TransMedics : Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation | ANDOVER, Mass., Sept. 29, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver f... |
| 07.09.2021 | TransMedics : Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S. | ANDOVER, Mass., Sept. 7, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fa... |
| 04.05.2021 | TransMedics Reports First Quarter 2021 Financial Results | |
| 02.03.2021 | TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results | |
| 04.11.2020 | TransMedics Reports Third Quarter 2020 Financial Results | |
| 02.01.2020 | Healthcare IPOs in 2019: The rise of digital health and biopharma unicorns (Updated) | Photo: jxfzsy, Getty Images
Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The publi... |
| 26.05.2016 | Organ Transplant Therapy Company TransMedics Closes $51.2M Equity Financing | TransMedics, Inc., an Andover, MA-based medical technology company dedicated to improving organ tranplant procedures, closed a $51.2m growth equity financing.
The round was co-led by global life science investors Fayerweather Fund, Pharmsta... |
| 04.06.2015 | TransMedics raises $20M for “living organ transplant” device | Most recently, The Lancet published an interesting TransMedics study and accompanying editorial, “Donor heart preservation: straight up, or on the rocks?”
The short-term outcomes for hearts in cold static storage were comparable to those in... |
| 27.10.2014 | TransMedics heart preservation system used in Aussie transplants | Transmedics said surgeons in Australia used its organ care system to preserve and assess a trio of hearts from donors whose organs had stopped beating, before the hearts were successfully transplanted.
Andover, Mass.-based TransMedics said ... |
| 28.11.2012 | Boston Deals: Incentive Targeting, Nantero, A123, TransMedics & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
[Updated 2:30 pm] A flurry of Boston-area investment and acquisition news hitting our radar screens today:
—Incentive Targeting, a startup that priovides Web-based behavioral ... |
| 27.11.2012 | Organ storage machine ensures heart arrives beating, lungs breathing for transplant (video) | The financing round was led by Abrams Capital along with existing investors such as Flagship Ventures, Hercules Technology Growth Capital and Kleiner Perkins Caufield & Byers.
Promoted
Telemedicine’s potential to provide healthcare to t... |
| 27.11.2012 | TransMedics Closes $36M Financing | TransMedics, Inc., an Andover, Massachusetts-based developer of organ preservation technology, has closed a $36m financing.
The round was led by Abrams Capital with participation of existing investors Flagship Ventures, Hercules Technology ... |
| 26.11.2012 | TransMedics Grabs $36.15M Venture Round |
ANDOVER, MA, Medical device company has raised $36 million in venture capital.
>> Click here for more funding data on TransMedics
>> To export TransMedics funding data to PDF and Excel, click here
TransMedics, a medical d... |
| 08.11.2011 | Invacare makes bit bets on Capitol Hill | MassDevice.com On Call | MASSDEVICE ON CALL — Health equipment giant Invacare Corp. (NYSE:IVC) isn’t getting much bang for its political buck, according to chairman Malachi Mixon.
The company has spent nearly $8 million on lobbying efforts since 2005 and Mixon and ... |
| 15.08.2011 | TransMedics Raises $5.9M |
Flagship Ventures is an investor in the medical device company.
>> Click here for more funding data on TransMedics
>> To export TransMedics funding data to PDF and Excel, click here
ANDOVER, MA, TransMedics, an Andover-ba... |
| 22.04.2010 | Healthcare Dominates Massachusetts’ Top 10 Deals | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Earlier this week, my colleague Bruce took a look at venture capital activity across the country in the first quarter of 2010, and found that investors were sinking more cash ... |
| 04.03.2010 | TransMedics Secures $36M Round of Financing | TransMedics, Inc., an Andover, Massachusetts-based medical device company focusing on delivering a system which maintains donor organs in functioning condition during transport, completed a $36m financing round.
The financing was lead by Fo... |
| 17.09.2007 | Life sciences briefing: Monday, Sept. 17, 2007 | Featured companies: Bioptigen, Echo Therapeutics, Forest Laboratories, Intrinsic Therapeutics, Microbia, Phreesia, Sontra Medical, TransMedics, Xanthus Pharmaceuticals
[NOTE: This is a catchup briefing, posted on 9/28/07. I’ve adjusted the ... |
| 24.07.2007 | New England’s Top 10 Q2 Venture Deals | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Yesterday we told you about the largest second-quarter venture deals in Massachusetts. Today we’re feeling more expansive, so below are the top 10 for New England. (Thanks aga... |
| 23.07.2007 | Top 10 Second-Quarter Venture Deals in Massachusetts | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The second-quarter wasn’t good for Boston area venture investing, at least in overall dollar terms. The area didn’t do so well in big individual deals, either. Whereas in Q1, ... |
| 14.03.2006 | TransMedics Inc., makers of first device to maintain functioning organs outside the body, raises $29.75m funding led by 3i | A privately held medical device company founded in 1998 to address the unmet need for better, more effective organ transplant technologies, announced today that it has raised $29.75 million in Series C financing.
The company's breakthrough... |
| - | Organ storage machine ensures heart arrives beating, lungs breathing for transplant (video) | A medical device company with an organ transport system for heart and lungs that could extend the amount of time organs can be kept outside of the body, potentially increasing the number of organ transplants, has raised $36 million.
Andover... |
| - | Healthcare IPOs in 2019: The rise of digital health and biopharma unicorns (Updated) | Note: This post has been updated with data from Cooley
Despite the fact that 2019 was a big year for digital health initial public offerings after a quiet couple of years, biopharma companies continued to dominate healthcare and life scienc... |
| - | TransMedics raises $20M for “living organ transplant” device | This one’s a step above a picnic cooler: Boston devicemaker TransMedics has developed a “living organ transplant” device that keeps organs in better condition prior to transplant surgery. Rather than keeping them cooling on ice – the curren... |
